Paron Dekumyoy Selected Research

Paron Dekumyoy Research Topics

Disease

12	Infections 03/2023 - 01/2003
12	Gnathostomiasis 03/2023 - 03/2004
7	Angiostrongyliasis 03/2023 - 01/2005
6	Trichinellosis 11/2022 - 03/2004
6	Opisthorchiasis 08/2020 - 09/2002
5	Strongyloidiasis 10/2022 - 01/2002
5	Parasitic Diseases (Parasitic Disease) 12/2021 - 07/2008
5	Paragonimiasis 05/2018 - 01/2005
4	Filarial Elephantiasis (Lymphatic Filariasis) 07/2010 - 01/2005
4	Echinococcosis (Hydatid Cysts) 07/2010 - 03/2004
3	Helminthiasis (Helminthiases) 01/2019 - 01/2002
3	Toxocariasis 07/2010 - 03/2004
2	Schistosomiasis (Bilharziasis) 01/2020 - 03/2004
2	Cysticercosis 11/2016 - 03/2004
2	Malaria 01/2013 - 01/2012
2	Ascariasis 07/2010 - 01/2005
2	Taeniasis 07/2010 - 01/2005
2	Neurocysticercosis 07/2010 - 01/2005
1	Dirofilariasis 03/2023
1	Larva Migrans (Cutaneous Larva Migrans) 03/2023
1	COVID-19 10/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Hemoptysis 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Cross Infection (Nosocomial Infection) 05/2018
1	Inflammation (Inflammations) 09/2017
1	Asthma (Bronchial Asthma) 09/2017
1	Hematologic Neoplasms (Hematological Malignancy) 08/2016
1	Meningitis 07/2010
1	Enterobiasis 07/2010
1	Falciparum Malaria (Plasmodium falciparum Malaria) 06/2006
1	Cysts 01/2006
1	Dizziness (Lightheadedness) 05/2005
1	Nausea 05/2005
1	Hookworm Infections (Hookworm Infection) 01/2005
1	Enoplida Infections 01/2005
1	Trichuriasis 01/2005
1	Sparganosis 01/2005
1	Fascioliasis 03/2004
1	Hymenolepiasis 09/2002

Drug/Important Bio-Agent (IBA)

19	AntigensIBA 11/2022 - 01/2002
12	Immunoglobulin G (IgG)IBA 03/2023 - 01/2002
7	Proteins (Proteins, Gene)FDA Link 08/2022 - 07/2010
6	AntibodiesIBA 03/2023 - 01/2005
3	Albendazole (Albenza)FDA Link 12/2021 - 05/2005
3	Recombinant ProteinsIBA 05/2018 - 11/2016
2	ImmunosorbentsIBA 11/2022 - 12/2016
2	EnzymesIBA 11/2022 - 12/2016
2	CytokinesIBA 01/2022 - 09/2017
2	Immunoglobulin E (IgE)IBA 12/2021 - 02/2014
2	Ivermectin (Mectizan)FDA Link 12/2021 - 05/2005
2	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 01/2010
2	SerpinsIBA 01/2019 - 09/2012
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2019 - 09/2012
1	Complex MixturesIBA 03/2023
1	Immunologic Factors (Immunomodulators)IBA 10/2022
1	Caspase 8 (Caspase-8)IBA 08/2022
1	ZincIBA 01/2022
1	Superoxide Dismutase-1IBA 01/2022
1	Interleukin-6 InhibitorsIBA 01/2022
1	Cathepsin BIBA 01/2022
1	CollagenIBA 01/2022
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2022
1	PeroxiredoxinsIBA 01/2022
1	Matrix Metalloproteinase 13IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 12/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2021
1	Peptides (Polypeptides)IBA 08/2020
1	Praziquantel (Biltricide)FDA Link 01/2020
1	AnthelminticsIBA 01/2020
1	myricetinIBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 09/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2016
1	AgarIBA 08/2016
1	SugarsIBA 01/2013
1	Artificial Membranes (Artificial Membrane)IBA 01/2013
1	Complementary DNA (cDNA)IBA 01/2012
1	Muramidase (Lysozyme)IBA 01/2012
1	Recombinant Fusion ProteinsIBA 07/2010
1	OccludinIBA 06/2006
1	VinculinIBA 06/2006
1	Alkaline PhosphataseIBA 05/2005
1	sephacryl S 200IBA 03/2004
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 01/2002

Therapy/Procedure

1	Therapeutics 09/2017
1	Drug Therapy (Chemotherapy) 08/2016
1	Aftercare (After-Treatment) 01/2009